Your browser doesn't support javascript.
loading
Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma.
Bergsma, Emilie J; Elgawly, Mariam; Mancuso, David; Orr, Roger; Vuskovich, Theresa; Seligson, Nathan D.
Affiliation
  • Bergsma EJ; Department of Pharmacy, University of Florida Health Shands Hospital, Gainesville, FL, USA.
  • Elgawly M; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.
  • Mancuso D; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.
  • Orr R; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.
  • Vuskovich T; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.
  • Seligson ND; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.
Ann Pharmacother ; 58(4): 407-415, 2024 Apr.
Article in En | MEDLINE | ID: mdl-37466080

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Alveolar Soft Part / B7-H1 Antigen Limits: Adult / Child / Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Alveolar Soft Part / B7-H1 Antigen Limits: Adult / Child / Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States